In Brief: Campana Alerta
This article was originally published in The Tan Sheet
Executive Summary
Campana Alerta: Federal Trade Commission issues final consent agreements Sept. 19 prohibiting San Juan, Puerto Rico-based Efficient Labs from making unsubstantiated claims that its dietary supplement Venoflash removes "dangerous clogs in the circulatory system" and treats varicose veins and hemorrhoids. FTC also gives final approval to consent agreement with Glendale, Calif.-based Leeka Products preventing marketer of Super Formula Reductora, Crema Sudadora Perfect Shape and Tratamiento para Combatir la Caida del Cabello ("Treatment to fight hair loss") from making unsubstantiated claims. The agreements were announced as part of FTC's campaign to "prevent deceptive health-related advertisements directed at Spanish-speaking consumers" ("The Tan Sheet" July 7, p. 13)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning